Ledipasvir and Sofosbuvir Tablets Price And Quantity
As required by client. Box
60 USD ($)
Ledipasvir and Sofosbuvir Tablets Product Specifications
Adults
As Directed By Physician.
Store in a cool and dark place.
As Directed By Physician.
Ledipasvir and Sofosbuvir Tablets Trade Information
Hazira / Nhava Sheva
Telegraphic Transfer (T/T) Cash in Advance (CID) Cash Advance (CA)
1000000 Box Per Month
1-2 Week
Yes
If order is confirmed we will reimburse the sample cost
Western Europe Australia North America South America Eastern Europe Middle East Africa Central America Asia
WHO-GMP/
GMP/
COA/
As Required By Client
Product Description
Product Details:
Brand
SOFOCRUZ LP
We Salvavidas Pharmaceutical Pvt Ltd are a leading Manufacturer and Exporter of SOFOCRUZ LP TABLET (Sofosbuvir 400mg + Ledipasvir 90mg ) in different strength and packing. Our manufacturing facility is certified with WHO-GMP.
Active Ingredients(Generic Name) : Sofosbuvir 400mg + Ledipasvir 90mg
Company Name: Torrent Pharmaceuticals Ltd
Strength : 400 mg + 90 mg
Package: 28 tabs
Pack Type: Bottle
Indication:
SOFOCRUZ LP Contain Sofosbuvir and Ledi pasvir For the treatment of Hepatitis C. Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.
The hepatitis C virus is a blood borne virus and the most common modes of infection are through unsafe injection practices, inadequate sterilization of medical equipment, and the transfusion of unscreened blood and blood products.
Globally, between 130-150 million people globally have chronic hepatitis C infection.
A significant number of those who are chronically infected will develop liver cirrhosis or liver cancer.
There is currently no vaccine for hepatitis C; however, research in this area is ongoing.
The hepatitis C virus is a blood borne virus. It is most commonly transmitted through:
injecting drug use through the sharing of injection equipment;
the reuse or inadequate sterilization of medical equipment, especially syringes and needles in healthcare settings; and
The transfusion of unscreened blood and blood products.
Uses:- Treating chronic hepatitis C virus (HCV) infection in certain patients. Ledipasvir and sofosbuvir is a combination of 2 hepatitis C virus (HCV) antiviral agents. It reduces the amount of HCV in the body by preventing the spread of the HCV within the body.